0001493152-23-043200.txt : 20231130 0001493152-23-043200.hdr.sgml : 20231130 20231130151222 ACCESSION NUMBER: 0001493152-23-043200 CONFORMED SUBMISSION TYPE: 8-A12B PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20231130 DATE AS OF CHANGE: 20231130 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aimei Health Technology Co., Ltd. CENTRAL INDEX KEY: 0001979005 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: 8-A12B SEC ACT: 1934 Act SEC FILE NUMBER: 001-41880 FILM NUMBER: 231455399 BUSINESS ADDRESS: STREET 1: 10 EAST 53RD STREET STREET 2: SUITE 3001 CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 34 678 035200 MAIL ADDRESS: STREET 1: 10 EAST 53RD STREET STREET 2: SUITE 3001 CITY: NEW YORK STATE: NY ZIP: 10022 8-A12B 1 form8a-12b.htm

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 8-A

 

FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES

PURSUANT TO SECTION 12(b) OR 12(g) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Aimei Health Technology Co., Ltd.

(Exact Name of Registrant as Specified in its Charter)

 

Cayman Islands   N/A
(State of Incorporation   (I.R.S. Employer
or Organization)   Identification No.)

 

10 East 53rd Street, Suite 3001

New York, NY 10022

(Address of Principal Executive Offices)

 

Securities to be registered pursuant to Section 12(b) of the Act:

 

Title of Each Class to be so Registered

  

Name of Each Exchange on Which Each Class is to be Registered

     
Ordinary Shares, par value of $0.0001 per share   The NASDAQ Stock Market LLC
     
Rights   The NASDAQ Stock Market LLC
     
Units, each consisting of one Ordinary Share and one Right   The NASDAQ Stock Market LLC

 

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c) or (e), check the following box. ☒

 

If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d) or (e), check the following box. ☐

 

If this form relates to the registration of a class of securities concurrently with a Regulation A offering, check the following box. ☐

 

Securities Act registration statement file number to which this form relates: 333-272230.

 

Securities to be registered pursuant to Section 12(g) of the Act: None.

 

 

 

 

 

 

Item 1. Description of Registrant’s Securities to be Registered.

 

A description of the ordinary shares, rights and units to be registered hereunder is contained in the section entitled “Description of Securities” in the Prospectus included in Aimei Health Technology Co., Ltd.’s (the “Registrant”) Registration Statement on Form S-1 (Registration No. 333-272230) initially filed with the Securities and Exchange Commission on May 26, 2023, as amended from time to time (the “Registration Statement”). This information is incorporated herein by reference. Any form of prospectus or prospectus supplement to the Registration Statement that includes such descriptions and that are filed subsequently to the Registration Statement are hereby also incorporated by reference herein.

 

Item 2. Exhibits.

 

Under the Instructions as to Exhibits with respect to Form 8-A, no exhibits are required to be filed because no other securities of the Registrant are registered on the NASDAQ Stock Market LLC and the securities registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.

 

Date: November 30, 2023 AIMEI HEALTH TECHNOLOGY CO., LTD
     
  By: /s/ Juan Fernandez Pascual
  Name: Juan Fernandez Pascual
  Title: Chief Executive Officer